Recombinant Topoisomerase II alpha antibody (AA 1431-1531)
Quick Overview for Recombinant Topoisomerase II alpha antibody (AA 1431-1531) (ABIN7859125)
Target
See all Topoisomerase II alpha (TOP2A) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1431-1531
-
Purpose
- Recombinant Topoisomerase II alpha (Proliferation & Drug-Resistance Marker) Antibody
-
Specificity
- The topoisomerase II-± isoform is a 170kDa nuclear protein and plays an important role in DNA synthesis and RNA transcription, as well as chromosomal segregation during mitosis. Topoisomerase II-± is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells, and has been shown to be over-expressed in many human cancers. Decreased expression of Topoisomerase II-± is the predominant mechanism of resistance to several chemotherapeutic agents.
-
Purification
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Synthetic peptide corresponding to Topo II α residues within aa1431-1531 of Topo II α
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))
-
Alternative Name
- Topoisomerase II alpha
-
Background
-
ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, Topoisomerase DNA II alpha 170 kDa, TP2A
Human tonsil or esophagus.
-
Molecular Weight
- 170kDa
-
Gene ID
- 7153, 156346
-
UniProt
- P11388
-
Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases
Target
-